Facebook Twitter YouTube SoundCloud RSS
 

Sweden Suspends Moderna mRNA Injections After Patients Develop Crippling Heart Condition


With each passing week, the statistics continue to mounts showing dangerous heart complications as a result of unsuspecting people injecting experimental mRNA gene-based COVID-19 jabs made by Pfizer and Moderna. 

Moderna is no stranger to vaccine controversy, as a number of health authorities have moved to stop their dubious experimental pharmaceutical cocktails from making their way further into the population. In August, Japanese health authorities announced they would shelve over 1.6 million doses of Moderna’s coronavirus ‘vaccine’ after reports of tainted vials. This was just one of many instances where dangerous products and adverse reactions have moved regulators to dump Moderna’s dodgy product line.

Now Swedish health officials are having second thoughts about giving these problematic jabs to any more of its citizens.

Jack Davis from Western Journal reports…

New concerns are being raised about side effects from the Moderna vaccine against the coronavirus. Swedish health officials have now decided that a moratorium on giving the Moderna vaccine to anyone under 31 will be extended indefinitely, the U.K. Daily Mail reported. The pause on the Moderna shots had been scheduled to end on Dec. 1.

Finland, Iceland and Denmark have taken similar steps. Norway is encouraging men under 30 not to get the Moderna shot, but is not mandating it.

For months, the Moderna vaccine has been under scrutiny because of data that shows young men who receive it are at increased risk for myocarditis, an inflammation of the heart muscle, and pericarditis, an inflammation of the sac around the heart.

The Daily Mail reported that one U.S. study that has not yet been peer-reviewed concluded that “young males under [age] 20 are up to six times more likely to develop myocarditis after contracting COVID-19 than those who have been vaccinated.”

The decision comes as the U.S. Food and Drug Administration is putting Moderna’s plans for a shot aimed at the population from age 12 to 17 on hold due to concerns over risks of the ailments, according to The Wall Street Journal.

Although a federal Centers for Disease Control and Prevention panel on Thursday approved boosters for the Moderna and Johnson & Johson vaccines, there were some cautions raised, according to CNBC.

Dr. Tom Shimabukuro said there is an increased risk of myocarditis and pericarditis with either the Moderna or Pfizer vaccine, in particular after the second dose of the vaccines.

According to the Daily Mail, the data indicated the risk was 13 times greater for those getting the Moderna vaccine than for those who got the Pfizer vaccine.

Continue this story at Western Journal

READ MORE VACCINES NEWS AT: 21st Century Wire Vaccines Files

PLEASE HELP SUPPORT OUR INDEPENDENT MEDIA PLATFORM HERE